By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
News Center

Press releases

Text Link

November 22, 2022

Exclusive commercial agreement for the distribution of a diagnostic test that predicts response to a treatment for pancreatic cancer

(French only)
Text Link

October 27, 2022

Half-year financial report available

(French only)
Text Link

October 11, 2022

H1 2022 Results: continued growth of non-COVID activity

(French only)
Text Link

October 3, 2022

Eurobio Scientific finalizes the acquisition of GenDx, international HLA diagnostics specialist

(French only)
Text Link

August 17, 2022

Eurobio Scientific signs an agreement to acquire GenDx, international HLA diagnostics specialist

(French only)
Text Link

July 25, 2022

First half turnover of €83.6 million maintained at a high level

(French only)
Text Link

July 11, 2022

Half-year report on liquidity contract

(French only)
Text Link

June 20, 2022

Launch of 2 new proprietary tests : new variants of SARS-CoV-2, and Monkeypox

(French only)
Text Link

June 14, 2022

Eurobio Scientific's annual shareholders' meeting

(French only)
Text Link

June 13, 2022

Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV

(French only)
Text Link

May 18, 2022

Closing of the Strategic Partnership with NEXTSTAGE AM

(French only)
Text Link

April 26, 2022

Eurobio Scientific partners with Dr. Nino Guy Cassuto for the development of a new PCR test for male fertility

(French only)
Text Link

April 14, 2022

CE mark for Eurobio Scientific’s new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2

(French only)
Text Link

April 6, 2022

Maintaining high level results in 2021

(French only)
Text Link

March 10, 2022

New priority test for the detection of Omicron BA.x, BA.2 and Delta of SARS-CoV-2

(French only)
Text Link

February 7, 2022

Strategic partnership with NextStage AM

(French only)
Text Link

January 24, 2022

2021 TURNOVER : Exceptional level of €184.1million

(French only)
Text Link

January 11, 2022

Eurobio Scientific launches the exclusive distribution of the first saliva self-test for HIV testing in France

(French only)
Text Link

December 13, 2021

Eurobio Scientific obtains CE marking for its proprietary test for Covid-19 screening and detection of the Omicron and Delta variants

(French only)
Text Link

November 30, 2021

Omicron variant : Eurobio Scientific launches the first PCR test allowing simultaneous SARS-CoV-2 virus screening and detection of the Delta and Omicron variants in a single reaction

(French only)
Text Link

November 23, 2021

Eurobio Scientific makes a minority investment in Usense

(French only)
Text Link

October 12, 2021

2021 Half-year earnings : EBITDA up +110% to €42.5m

(French only)
Text Link

October 6, 2021

Eurobio Scientific receives a $430,000 milestone payment from Allergan

(French only)
Text Link

July 26, 2021

First half turnover reaches €95.7 million, a 54% increase

(French only)
Text Link

May 26, 2021

Eurobio Scientific launches a new proprietary test for simultaneous detection of the SARS-CoV-2 virus and characterization of its new mutations

(French only)
Text Link

April 29, 2021

Exceptional 2020 results

(French only)
Text Link

March 9, 2021

EUROBIO Scientific extends its family of proprietary PCR tests to allow the identification of SARS-CoV-2 variants

(French only)
Text Link

January 25, 2021

Exceptional 2020 turnover of € 189 million (+220%)

(French only)
Text Link

January 18, 2021

Eurobio Scientific expands its range of COVID-19 tests with an antigenic rapid test

(French only)
Text Link

October 15, 2020

2020 half-year results : EBITDA at €20.3 M

(French only)
Text Link

September 22, 2020

Eurobio Scientific launches a first rapid diagnostic test for the detection of the SARS CoV-2 virus antigen

(French only)
Text Link

September 15, 2020

Eurobio Scientific announces the CE marking of its COVID EBX FluCoSyn™ PCR test

(French only)
Text Link

July 21, 2020

Very strong growth of business during the first half of 2020

(French only)
Text Link

July 15, 2020

Eurobio Scientific expands into Switzerland, Germany, Austria and Benelux with the acquisition of TECOmedical AG

(French only)
Text Link

June 9, 2020

CNR validation of two COVID-19 serology tests

(French only)
Text Link

May 13, 2020

Eurobio Scientific and the Hospices Civils de Lyon join forces to develop a bank of anti-SARS CoV-2 antibodies

(French only)
Text Link

May 11, 2020

Eurobio Scientific's proprietary PCR test confirmed as part of the fight against COVID-19

(French only)
Text Link

May 5, 2020

Eurobio Scientific and NG Biotech enter into a marketing agreement for COVID-19 serology rapid tests

(French only)
Text Link

April 14, 2020

Strong growth of 2019 annual results

(French only)
Text Link

March 31, 2020

Eurobio Scientific launches MagLumi COVID-19 automated test from its partner SNIBE for COVID-19 serology

(French only)
Text Link

March 25, 2020

Eurobio Scientific gets CE marking for its proprietary COVID-19 test

(French only)
Text Link

January 27, 2020

Eurobio Scientific anounced full-year revenues up 17% to €59.1M

(French only)
Text Link

November 4, 2019

Eurobio Scientific enters into a strategic agreement for the development of proprietary products in molecular biology

(French only)
Text Link

October 15, 2019

Strong Earnings Growth for the First Half of 2019

(French only)
Text Link

October 1, 2019

Eurobio Scientific joins the Enternext PEA PME 150 index

(French only)
Text Link

July 23, 2019

First Semester 2019 : strong growth of sales

(French only)
Text Link

June 12, 2019

Eurobio Scientific and Vivo Medical Group enter into exclusive negociations for the acquisition of two companies in the United Kingdom

(French only)
Text Link

April 17, 2019

Eurobio Scientific - 2018 annual results

(French only)
Text Link

January 29, 2019

Eurobio Scientific reaches the €50M sales mark in 2018

(French only)
Text Link

January 8, 2019

Eurobio Scientific announces its financial communication calendar for 2019

(French only)
Text Link

October 31, 2018

Lending of bond funds of €2.5M with Vatel Direct (French version)

(French only)
Text Link

October 23, 2018

EUROBIO SCIENTIFIC certified ISO 13485 V2016

(French only)
Text Link

October 17, 2018

Eurobio Scientific and BIOGROUP-LCD enter into an agreement for the supply and maintenance of Multiplex Molecular Biology automated platforms

(French only)
Text Link

October 9, 2018

Eurobio Scientific - 2018 mid-year results

(French only)
Text Link

July 23, 2018

Consolidated turnover for the fist semester of 2018 increases by 29%

(French only)
Text Link

July 16, 2018

Eurobio Scientific acquires Dendritics, a company specializing in antibody development and manufacture

(French only)
Text Link

June 25, 2018

Eurobio Scientific will market the Quidel Triage range (PR in French)

(French only)
Text Link

June 21, 2018

Change of Eurobio scientific listing name and code by Euronext (PR in French)

(French only)
Text Link

June 14, 2018

Company name changed to Eurobio scientific, annual shareholders meeting (PR in French)

(French only)
Text Link

May 2, 2018

Renewal of the partnership with One Lambda in transplantation (PR in French)

(French only)
Text Link

April 23, 2018

DIAXONHIT – Group 2017 annual results (PR in French)

(French only)
Text Link

October 30, 2017

DIAXONHIT – 2017 mid-year results (PR in French)

(French only)
Text Link

September 5, 2017

Diaxonhit acquires GENBIO in the US (PR in French)

(French only)